The diabetes epidemic continues to surge with the disease affecting an estimated 382 million people worldwide. But a large gap exists in the research and funding, making understanding these ebbs and flows pivotal in continuing to understand the landscape. That’s why we’ve released a new analysis today that identifies the top 34 global funders of diabetes research.
The analysis was conducted by Thomson Reuters ScienceWatch analysts and found that the U.S. National Institutes of Health is the leading funding organization with 13,436 acknowledgements, followed by the National Natural Science Institute of China with 3,354 acknowledgements, and the Juvenile Diabetes Research Foundation (JDRF) with 2,547 acknowledgements. Other top 35 funders include government agencies such as the Canadian Institutes of Health Research; the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the American Heart Association, as well as global pharmaceutical giants such as Novo Nordisk and Pfizer.
However, several regions that are strongly impacted by the disease were notably absent from the list. According to the International Diabetes Federation, an estimated 20 million people live with the disease in Africa, and the continent has the highest global rate of mortality, but no African organizations were listed among the top funding agencies. Africa-based researchers did contribute to 1,581 diabetes-related papers.
In addition, regions of Southeast Asia, the Middle East, and India are similarly afflicted, but their research output does not yet measure up. Sixty five million of India’s 1.2 billion people are affected by diabetes, but no India-based organizations have yet emerged among the 35 most-prolific funders.
To view the infographic that further illustrates this regional imbalance, visit http://sciencewatch.com/sites/sw/files/sw-article/media/sw-diabetes-infographic.pdf